TLA
GILD icon

Tanglewood Legacy Advisors’s Gilead Sciences GILD Stock Holding History

Tanglewood Legacy Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-120
Closed -$8.79K – 289
2024
Q1 		$8.79K Hold
120
– – ﹤0.01% 252
2023
Q4 		$9.72K Hold
120
– – 0.01% 243
2023
Q3 		$8.99K Hold
120
– – 0.01% 250
2023
Q2 		$9.25K Hold
120
– – 0.01% 247
2023
Q1 		$9.96K Hold
120
– – 0.01% 242
2022
Q4 		$10.3K Buy
+120
New +$9.5K 0.01% 210

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Tanglewood Legacy Advisors's GILD Position: Q2 2024 in Review

Tanglewood Legacy Advisors sold out of Gilead Sciences (GILD) in Q2 2024, closing a stake of 120 shares — an estimated $8.79K sold.

Tanglewood Legacy Advisors first reported a position in GILD in Q4 2022 and held it in 6 quarters. The position peaked at $10.3K in Q4 2022. 1,678 funds tracked by Wall St. Rank hold GILD as of Q2 2024.

  • Tanglewood Legacy Advisors reported no remaining Gilead Sciences position as of Q2 2024 after selling out during the quarter.
  • Tanglewood Legacy Advisors sold 120 Gilead Sciences shares in Q2 2024, an estimated $8.79K.
  • Tanglewood Legacy Advisors first reported a position in Gilead Sciences in Q4 2022 and held it in 6 quarters.
  • Tanglewood Legacy Advisors's Gilead Sciences position peaked at $10.3K in Q4 2022.
  • 1,678 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.

Based on Tanglewood Legacy Advisors's 13F filing for Q2 2024, filed 17 Jul 2024.